(NYSE: NVRO) Nevro's forecast annual revenue growth rate of 5.15% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.62%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.23%.
Nevro's revenue in 2024 is $425,174,000.On average, 7 Wall Street analysts forecast NVRO's revenue for 2024 to be $16,094,451,861, with the lowest NVRO revenue forecast at $15,905,510,455, and the highest NVRO revenue forecast at $16,366,234,846. On average, 7 Wall Street analysts forecast NVRO's revenue for 2025 to be $17,069,041,549, with the lowest NVRO revenue forecast at $16,707,719,774, and the highest NVRO revenue forecast at $17,568,238,501.
In 2026, NVRO is forecast to generate $18,193,626,909 in revenue, with the lowest revenue forecast at $17,861,896,613 and the highest revenue forecast at $18,571,728,107.